Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-42587
Mar Drugs 2012 Aug 01;108:1647-1661. doi: 10.3390/md10081647.
Show Gene links Show Anatomy links

Preparation and characterization of O-acylated fucosylated chondroitin sulfate from sea cucumber.

Gao N , Wu M , Liu S , Lian W , Li Z , Zhao J .


Abstract
Fucosylated chondroitin sulfate (FuCS), a kind of complex glycosaminoglycan from sea cucumber, has potent anticoagulant activity. In order to understand the relationship between structures and activity, the depolymerized FuCS (dFuCS) was chosen to prepare its derivates by selective substitution at OH groups. Its O-acylation was carried out in a homogeneous way using carboxylic acid anhydrides. The structures of O-acylated derivatives were characterized by NMR. The results indicated that the 4-O-sulfated fucose residues may be easier to be acylated than the other ones in the sulfated fucose branches. But the O-acylation was always accompanied by the β-elimination, and the degree of elimination was higher as that of acylation was higher. The results of clotting assay indicated that the effect of partial O-acylation of the dFuCS on their anticoagulant potency was not significant and the O-acylation of 2-OH groups of 4-O-sulfated fucose units did not affect the anticoagulant activity.

PubMed ID: 23015767
PMC ID: PMC3447332
Article link: Mar Drugs


Genes referenced: LOC100887844


Article Images: [+] show captions
References [+] :
Buyue, Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite. 2009, Pubmed